SEC Form 4 · accession 0001011060-15-000015
AdvanSource Biomaterials Corp · ASNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Michael F Adams
Officer — President and CEO · Director
Period of report
Aug 18, 2015
Accepted (ET)
Aug 20, 2015 · 11:55 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001011060
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 18, 2015 | P | 130 | $0.08 | A | 549,834 | D | |
| Common StockF1 | Aug 18, 2015 | P | 10,000 | $0.96 | A | 559,834 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired through open market purchases.